Literature DB >> 24810574

Relapsed T-cell acute lymphoblastic leukaemia in the vitreous of an adult: a case report.

R Allchin1, A Pradeep2, R Sheard3, I G Rennie3, H S Mudhar4.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24810574      PMCID: PMC4135270          DOI: 10.1038/eye.2014.90

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

1.  Diagnostic cellular yield is superior with full pars plana vitrectomy compared with core vitreous biopsy.

Authors:  H S Mudhar; R Sheard
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

2.  Bullous exudative retinal detachment due to infiltration of leukemic cells in a child with acute lymphoblastic leukemia.

Authors:  Kenichi Yoshida; Daisuke Hasegawa; Ayako Takusagawa; Itaru Kato; Chitose Ogawa; Nariaki Echizen; Kishiko Ohkoshi; Tatsuo Yamaguchi; Ryota Hosoya; Atsushi Manabe
Journal:  Int J Hematol       Date:  2010-09-14       Impact factor: 2.490

3.  Central nervous system relapse in adults with acute lymphoblastic leukemia.

Authors:  Usha R Surapaneni; Jorge E Cortes; Deborah Thomas; Susan O'Brien; Francis J Giles; Charles Koller; Stefan Faderl; Hagop Kantarjian
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

4.  Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.

Authors:  Ajay Vora; Nick Goulden; Rachel Wade; Chris Mitchell; Jeremy Hancock; Rachael Hough; Clare Rowntree; Sue Richards
Journal:  Lancet Oncol       Date:  2013-02-07       Impact factor: 41.316

  4 in total
  1 in total

1.  A novel OCT signature in leukemic papillopathy masquerading as autoimmune or infectious uveitis.

Authors:  Jason M L Miller; Emily Chang; Cagri G Besirli; Mark W Johnson; Hakan Demirci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-04       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.